Physician
OIG excluded
Sonoran Desert Pathology Associates LLC
Sonoran Desert Pathology Associates LLC was paid $504K by Medicaid between Jan 2018 and Feb 2022, across 93 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 16% of everything it billed.
33Billing provider infoSONORAN DESERT PATHOLOGY ASSOCIATES LLC
MONTEREY PARK, CA 91754
MONTEREY PARK, CA 91754
33aNPI1205162955assigned 10/29/2009
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$504K
24GClaims93,031
24DCodes billed93
24AFirst – last monthJan 2018 – Feb 2022
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#55 of 222
Median peer was paid$42K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
OIG exclusionListed on the federal exclusion list (05/07/2024).
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,476 | $90K | |
| 2019 | 34,869 | $194K | |
| 2020 | 27,593 | $161K | |
| 2021 | 2,797 | $48K | |
| 2022 | 296 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16% | 1,676 | 1,111 | $80K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 15% | 1,417 | 1,382 | $74K |
| 88307 | 12% | 730 | 720 | $63K | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 5.6% | 274 | 270 | $28K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 5.2% | 398 | 319 | $26K |
| 82962 | 4.9% | 4,707 | 1,971 | $25K | |
| 88304 | 4.8% | 815 | 812 | $24K | |
| 88342 | 3.8% | 358 | 356 | $19K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.4% | 13,074 | 6,868 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.8% | 528 | 446 | $14K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.7% | 901 | 556 | $13K |
| 80053 | Comprehensive metabolic panel | 2.5% | 7,337 | 3,826 | $13K |
81 more codes
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.2% | 137 | $11K |
| 88302 | 1.7% | 270 | $9K | |
| 83735 | 1.1% | 4,272 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,116 | $5K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 483 | $5K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 97 | $4K |
| 85027 | <1% | 3,681 | $4K | |
| 87040 | <1% | 1,399 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,432 | $3K |
| 86141 | <1% | 1,578 | $3K | |
| 82805 | <1% | 580 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,317 | $3K |
| 86901 | <1% | 6,853 | $3K | |
| 86886 | <1% | 3,932 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 256 | $3K |
| 80061 | Lipid panel | <1% | 1,319 | $2K |
| 86900 | <1% | 5,044 | $2K | |
| 84100 | <1% | 2,591 | $2K | |
| 82746 | <1% | 890 | $2K | |
| 82550 | <1% | 2,106 | $2K | |
| 83605 | <1% | 1,039 | $2K | |
| 82728 | <1% | 795 | $2K | |
| 86880 | <1% | 1,877 | $2K | |
| 86920 | <1% | 25 | $1K | |
| 82607 | <1% | 517 | $1K | |
| 85730 | <1% | 1,023 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 847 | $1K |
| 84439 | <1% | 732 | $1K | |
| 84466 | <1% | 481 | $948.44 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 190 | $931.06 |
| 87186 | <1% | 467 | $904.30 | |
| 87541 | <1% | 164 | $850.20 | |
| 87581 | <1% | 162 | $850.05 | |
| 85610 | <1% | 1,180 | $831.88 | |
| 87486 | <1% | 163 | $811.06 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 36 | $702.53 |
| 83540 | <1% | 652 | $670.85 | |
| 80202 | <1% | 262 | $610.09 | |
| 85651 | <1% | 1,150 | $515.65 | |
| 87077 | <1% | 278 | $514.24 | |
| 82247 | <1% | 569 | $511.06 | |
| 87070 | <1% | 299 | $493.06 | |
| 87081 | <1% | 432 | $453.34 | |
| 84550 | <1% | 719 | $374.45 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 260 | $372.97 |
| 85379 | <1% | 221 | $371.45 | |
| 82140 | <1% | 124 | $306.44 | |
| 83550 | <1% | 269 | $291.13 | |
| 83880 | <1% | 49 | $274.68 | |
| 82009 | <1% | 256 | $212.93 | |
| 82570 | <1% | 191 | $171.14 | |
| 84484 | <1% | 77 | $169.13 | |
| 85384 | <1% | 103 | $145.00 | |
| 85007 | <1% | 320 | $142.39 | |
| 81001 | <1% | 267 | $139.02 | |
| 82248 | <1% | 150 | $133.68 | |
| 83690 | <1% | 99 | $128.75 | |
| 71045 | Radiologic examination, chest; single view | <1% | 18 | $103.23 |
| 80076 | <1% | 59 | $82.47 | |
| 81003 | <1% | 135 | $48.17 | |
| 80306 | <1% | 44 | $34.28 | |
| 83615 | <1% | 36 | $23.35 | |
| 84156 | <1% | 12 | $7.68 | |
| 85008 | <1% | 32 | $2.33 | |
| 81406 | 0% | 165 | $0.00 | |
| 86003 | 0% | 127 | $0.00 | |
| 81408 | 0% | 180 | $0.00 | |
| 81413 | 0% | 81 | $0.00 | |
| 81414 | 0% | 67 | $0.00 | |
| 81405 | 0% | 165 | $0.00 | |
| 81403 | 0% | 25 | $0.00 | |
| 82785 | 0% | 120 | $0.00 | |
| 81404 | 0% | 296 | $0.00 | |
| 81411 | 0% | 66 | $0.00 | |
| 81238 | 0% | 51 | $0.00 | |
| 81401 | 0% | 51 | $0.00 | |
| 81161 | 0% | 67 | $0.00 | |
| 80050 | General health panel | 0% | 77 | $0.00 |
| 81407 | 0% | 81 | $0.00 | |
| 84153 | 0% | 44 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGERSTEIN, ROBERT (MANAGING PARTNER)